Search

Rachel Nishimura Phones & Addresses

  • 3957 30Th St UNIT 406, San Diego, CA 92104 (808) 348-0151
  • Whittier, CA
  • Claremont, CA
  • 94-246 Keaolani St, Mililani, HI 96789

Resumes

Resumes

Rachel Nishimura Photo 1

Student At Fullerton College

View page
Location:
Orange County, California Area
Industry:
Publishing
Work:
The Hornet Sep 2007 - Dec 2007
News Editor

CosmoGIRL! Magazine Jul 2006 - Jul 2007
CG! Stringer

The Orange County Register Jun 2006 - Nov 2006
Intern
Education:
Fullerton College 2007 - 2009
Interests:
writing, layout, graphics, bitching, InDesign, Illustrator, pirated Adobe Software, Quark, my macbook pro, stalking, scheming, awkward silence, online shopping, making curry, lucid dreaming, debauchery, half asian boys, secret societies, oriental religions, tart yogurt flavors, staedtler writing tools, haribo gold bears, brewed teas, periodicals, vinyl, weezer b sides
Rachel Nishimura Photo 2

Manager, Program Management Leader

View page
Location:
3957 30Th St, San Diego, CA 92104
Industry:
Pharmaceuticals
Work:
The Janssen Pharmaceutical Companies of Johnson & Johnson
Associate Scientist Ii

The Janssen Pharmaceutical Companies of Johnson & Johnson Apr 2013 - Jun 2016
Associate Scientist I

The Janssen Pharmaceutical Companies of Johnson & Johnson Dec 2010 - Mar 2013
Assistant Scientist

Hawaii Gas Apr 2010 - Nov 2010
Associate Chemist

Harvey Mudd College Jan 2007 - Aug 2009
Undergraduate Researcher
Education:
Harvey Mudd College 2005 - 2009
Bachelors, Bachelor of Science, Chemistry
Harvey Mudd College;Bs, Chemistry;2005 – 2009;
Bachelors, Bachelor of Science, Chemistry
Skills:
Chemistry
Organic Chemistry
Medicinal Chemistry
Hplc
Drug Discovery
Biochemistry
Organic Synthesis
R&D
Inorganic Chemistry
Laboratory
Nmr
Analytical Chemistry
Physical Chemistry
Life Sciences
Languages:
English
Rachel Nishimura Photo 3

Rachel Nishimura

View page
Industry:
Writing And Editing

Publications

Us Patents

Phenyl And Pyridinyl Substituted Imidazoles As Modulators Of Rorgt

View page
US Patent:
20220281823, Sep 8, 2022
Filed:
May 5, 2022
Appl. No.:
17/737113
Inventors:
- Beers, BE
Connor L. Martin - San Diego CA, US
Elizabeth G. Fennema - La Mesa CA, US
David A. Kummer - San Diego CA, US
Rachel T. Nishimura - San Diego CA, US
Virginia M. Tanis - Vista CA, US
Craig R. Woods - San Diego CA, US
Anne M. Fourie - San Diego CA, US
Xiaohua Xue - San Diego CA, US
Assignee:
Janssen Pharmaceutica NV - Beerse
International Classification:
C07D 233/90
C07D 401/04
Abstract:
The present invention comprises compounds of Formula I.wherein:R, R, R, R, R, R, R, Q, and Qare defined in the specification.The invention also comprises a method of treating or ameliorating a ROR-γ-t mediated syndrome, disorder or disease, including wherein the syndrome, disorder or disease is selected from the group consisting of rheumatoid arthritis, psoriatic arthritis, and psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of Formula I.

Inhibitors Of Keap1-Nrf2 Protein-Protein Interaction

View page
US Patent:
20200055874, Feb 20, 2020
Filed:
Aug 19, 2019
Appl. No.:
16/544462
Inventors:
- Beerse, BE
Wenying Chai - San Diego CA, US
Gavin C. Hirst - San Diego CA, US
Kevin D. Kreutter - Arlington MA, US
David A. Kummer - San Diego CA, US
Kelly J. McClure - Ramona CA, US
Rachel T. Nishimura - San Diego CA, US
Amy Y. Shih - San Diego CA, US
Jennifer D. Venable - Solana Beach CA, US
Hariharan Venkatesan - San Diego CA, US
Jianmei Wei - San Diego CA, US
International Classification:
C07D 513/14
C07D 519/00
C07D 515/20
C07D 513/10
C07D 515/10
C07D 513/04
C07D 471/04
C07D 419/10
C07D 515/04
Abstract:
Sultam compounds, pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with the KEAP1-Nrf2 interaction, such as inflammatory bowel disease, including Crohn's disease and ulcerative colitis.

Phenyl Substituted Pyrazoles As Modulators Of Rorgt

View page
US Patent:
20190382349, Dec 19, 2019
Filed:
Jun 17, 2019
Appl. No.:
16/442837
Inventors:
- Beerse, BE
Connor L. Martin - San Diego CA, US
Elizabeth G. Fennema - La Mesa CA, US
David A. Kummer - San Diego CA, US
Rachel T. Nishimura - San Diego CA, US
Craig R. Woods - San Diego CA, US
Ronald L. Wolin - San Diego CA, US
William M. Jones - Jenkintown PA, US
Anne M. Fourie - San Diego CA, US
Xiaohua Xue - San Diego CA, US
Assignee:
Janssen Pharmaceutica NV - Beerse
International Classification:
C07D 231/14
C07D 401/12
C07D 403/10
C07D 405/12
Abstract:
The present invention comprises compounds of Formula I.wherein:R, R, R, R, R, R, R, and Q are defined in the specification.The invention also comprises a method of treating or ameliorating a ROR-γ-t mediated syndrome, disorder or disease, including wherein the syndrome, disorder or disease is selected from the group consisting of rheumatoid arthritis, psoriatic arthritis, and psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of Formula I.

Phenyl And Pyridinyl Substituted Imidazoles As Modulators Of Roryt

View page
US Patent:
20190382354, Dec 19, 2019
Filed:
Jun 17, 2019
Appl. No.:
16/442864
Inventors:
- Beerse, BE
Connor L. Martin - San Diego CA, US
Elizabeth G. Fennema - La Mesa CA, US
David A. Kummer - San Diego CA, US
Rachel T. Nishimura - San Diego CA, US
Virginia M. Tanis - Vista CA, US
Craig R. Woods - San Diego CA, US
Anne M. Fourie - San Diego CA, US
Xiaohua Xue - San Diego CA, US
Assignee:
Janssen Pharmaceutica NV - Beerse
International Classification:
C07D 233/90
C07D 401/04
Abstract:
The present invention comprises compounds of Formula I.wherein:R, R, R, R, R, R, R, Q, and Qare defined in the specification.The invention also comprises a method of treating or ameliorating a ROR-γ-t mediated syndrome, disorder or disease, including wherein the syndrome, disorder or disease is selected from the group consisting of rheumatoid arthritis, psoriatic arthritis, and psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of Formula I.

6-Aminopyridin-3-Yl Pyrazoles As Modulators Of Rorgt

View page
US Patent:
20190382373, Dec 19, 2019
Filed:
Jun 17, 2019
Appl. No.:
16/442897
Inventors:
- Beerse, BE
Connor L. Martin - San Diego CA, US
Elizabeth G. Fennema - La Mesa CA, US
David A. Kummer - San Diego CA, US
Rachel T. Nishimura - San Diego CA, US
Anne M. Fourie - San Diego CA, US
Xiaohua Xue - San Diego CA, US
Assignee:
Janssen Pharmaceutica NV - Beerse
International Classification:
C07D 401/14
C07D 401/04
A61P 37/02
Abstract:
The present invention comprises compounds of Formula I.wherein:R, Q, R, R, R, R, A, and Aare defined in the specification.The invention also comprises a method of treating or ameliorating a ROR-γ-t mediated syndrome, disorder or disease, including wherein the syndrome, disorder or disease is selected from the group consisting of rheumatoid arthritis, psoriatic arthritis, and psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of Formula I.

Alkyl Linked Quinolinyl Modulators Of Rorγt

View page
US Patent:
20170258782, Sep 14, 2017
Filed:
Mar 14, 2016
Appl. No.:
15/069030
Inventors:
- Beerse, BE
Kent Barbay - Flourtown PA, US
James P. Edwards - San Diego CA, US
Kevin D. Kreutter - Plainsboro NJ, US
David A. Kummer - San Diego CA, US
Umar Maharoof - North Wales PA, US
Rachel Nishimura - San Diego CA, US
Maud Urbanski - Flemington NJ, US
Hariharan Venkatesan - San Diego CA, US
Aihua Wang - Jamison PA, US
Ronald L. Wolin - San Diego CA, US
Craig R. Woods - San Diego CA, US
Anne Fourie - San Diego CA, US
Xiaohua Xue - San Diego CA, US
Maxwell D. Cummings - Ambler PA, US
International Classification:
A61K 31/4709
Abstract:
The present invention comprises compounds of Formula I.wherein:R, R, R, R, R, R, R, R, and Rare defined in the specification.The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim

Quinolinyl Modulators Of Roryt

View page
US Patent:
20170182056, Jun 29, 2017
Filed:
Mar 2, 2017
Appl. No.:
15/447917
Inventors:
- Beerse, BE
Kent Barbay - Sunnybrook PA, US
James P. Edwards - San Diego CA, US
Kevin D. Kreutter - Plainsboro NJ, US
David A. Kummer - San Diego CA, US
Umar Maharoof - North Wales PA, US
Rachel Nishimura - San Diego CA, US
Maud Urbanski - Flemington NJ, US
Hariharan Venkatesan - San Diego CA, US
Aihua Wang - Jamison PA, US
Ronald L. Wolin - San Diego CA, US
Craig R. Woods - San Diego CA, US
Anne Fourie - San Diego CA, US
Xiaohua Xue - San Diego CA, US
Maxwell D. Cummings - Ambler PA, US
Kelly McClure - Ramona CA, US
Virginia Tanis - Vista CA, US
Assignee:
Janssen Pharmaceutica NV - Beerse
International Classification:
A61K 31/5377
A61K 45/06
A61K 31/506
A61K 31/4985
A61K 31/4709
A61K 31/496
Abstract:
The present invention comprises compounds of Formula I.wherein:R, R, R, R, R, R, R, R, and Rare defined in the specification.The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim

Phenyl Linked Quinolinyl Modulators Of Rorgammat

View page
US Patent:
20160279122, Sep 29, 2016
Filed:
Jun 14, 2016
Appl. No.:
15/182231
Inventors:
- Beerse, BE
Kent Barbay - Flourtown PA, US
James P. Edwards - San Diego CA, US
Kevin D. Kreutter - Plainsboro NJ, US
David A. Kummer - San Diego CA, US
Umar Maharoof - North Wales PA, US
Rachel Nishimura - San Diego CA, US
Maud Urbanski - Flemington NJ, US
Hariharan Venkatesan - San Diego CA, US
Aihua Wang - Jamison PA, US
Ronald L. Wolin - San Diego CA, US
Craig R. Woods - San Diego CA, US
Anne Fourie - San Diego CA, US
Xiaohua Xue - San Diego CA, US
Maxwell D. Cummings - Ambler PA, US
International Classification:
A61K 31/4709
A61K 45/06
A61K 31/506
Abstract:
The present invention comprises compounds of Formula I.wherein:R, R, R, R, R, R, R, R, and Rare defined in the specification.The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim
Rachel T Nishimura from San Diego, CA, age ~37 Get Report